IV TRC105: Phase Ib data

Data from 17 evaluable patients with advanced or metastatic RCC in the dose-escalation Phase Ib portion of an open-label, U.S. Phase Ib/IIb trial showed that once-weekly 8 and 10 mg/kg doses of IV TRC...